Verisk Analytics (VRSK) — Q2 2026 Earnings Preview

Ticker: VRSK Upcoming Earnings Date: July 29, 2026 Preparation Date: July 28, 2026 Reporting Period: Q2 2026 (quarter ended June 30, 2026)

1. Earnings Preview

Key Takeaway: Setup is modestly constructive — consensus has been trimmed since Q1 earnings, management pre-guided Q2 OCC growth could still fall below the long-term target range, and the bar appears achievable; the biggest swing factor is whether transactional revenue (weather-driven) shows any sequential improvement or remains a drag.

Heading into Q2 2026, the bar for Verisk is deliberately low: management explicitly warned on the April 29 earnings call that Q2 OCC revenue growth could still fall below the 6–8% long-term target range, citing persistent year-over-year headwinds from low 2025 weather activity, tough subscription renewal comparisons from a strong prior-year cycle, and the carryover of a federal government contract work stoppage. Consensus revenue sits at ~$804M (+4.1% YoY) and operating EPS at ~$1.93, both modestly below the prior-year Q2 actuals on a growth-rate basis — a low bar that management's own language has effectively set. Guidance tone has been stable-to-constructive since Q1: at the Bernstein conference (May 28), CEO Lee Shavel confirmed Q1 was the trough and expressed confidence in 'continued momentum into Q2,' and at William Blair (June 2) reiterated the 6–8% organic growth algorithm for the next three years. Estimate revisions have drifted slightly lower since the Q1 print — Q2 revenue consensus fell from ~$801.8M to ~$804.5M (a modest upward drift) while EPS moved from ~$1.91 to ~$1.93 — suggesting the street has largely digested the guidance and is not pricing in a meaningful surprise in either direction.

The stock has rallied ~12.8% since the April 29 earnings date (from $188.19 to $212.26 as of July 28), meaningfully outperforming the KIE insurance ETF (+16.1%) and the S&P 500 (+4.1%) over the same window, with the bulk of the move driven by multiple re-expansion rather than estimate upgrades — the NTM EV/EBITDA has expanded from ~13.96x three months ago to ~16.36x today. The stock is not cheap heading into the print, but the setup is not stretched either given the trough narrative is well-understood. The key wildcard is weather activity in Q2 2026: Progressive's Q2 results showed a net catastrophe loss ratio of 2.4% companywide (with property at 8.9%), and Travelers reported ~$400M after-tax cat losses — both suggesting more normalized weather than the near-zero activity of 2025, which could provide a modest transactional revenue tailwind for Verisk's property and restoration solutions. A second wildcard is the CIO transition announced July 27 (effective August 3), which adds a minor leadership uncertainty overhang heading into the call.

2. KPIs & Consensus Expectations

Key Takeaway: Consensus sets a low bar on both revenue (~$804M, +4.1% YoY) and operating EPS (~$1.93, +2.7% YoY), consistent with management's own guidance that Q2 OCC growth may still fall below the long-term 6–8% target range. Organic CC growth and the subscription/transactional revenue split are the bigger swing factors — any improvement in transactional revenue from weather normalization could push the print above the low bar.

Table 1 — Current Quarter Snapshot (Q2 2026)

KPI

Q1 2026 Actual (Last Quarter)

Q2 2025 Actual (Prior Year Period)

Q2 2026 Consensus Estimate

YoY Change (Est. vs. PY)

FY 2026 Guidance (Midpoint)

Consensus vs. Guidance

Revenue ($M)

$782.6M

$772.6M

$804.5M

+4.1%

$3,215M midpoint ($3,190–$3,240M)

~+0.3% above midpoint run-rate

Adj. Operating EPS ($)

$1.82

$1.88

$1.93

+2.7%

$7.60 midpoint ($7.45–$7.75)

On track with FY guide

Adj. EBITDA ($M)

$437.5M

$444.8M

$456.9M

+2.7%

$1,810M midpoint ($1,790–$1,830M)

~+0.9% above midpoint run-rate

Organic CC Revenue Growth (%)

4.7%

7.9%

~5.3%

-260 bps YoY

6–8% LT target; FY2026 ~6.1% consensus

Below LT range; mgmt guided Q2 may still be below

Subscription OCC Growth (%)

7.0%

9.3%

~7.2%

-210 bps YoY

N/A (no specific Q2 sub guidance)

N/A

Transactional OCC Growth (%)

-6.1%

+1.8%

~-3.6%

Negative vs. +1.8% PY

N/A (weather-dependent)

N/A

Free Cash Flow ($M)

$326.4M

$188.7M

$208.7M

+10.6%

N/A (FY consensus ~$1,118M)

N/A

Sources: Visible Alpha Consensus and Actuals Data (Revenue, EPS, EBITDA, OCC Growth, FCF); Q1 2026 Earnings Release (April 29, 2026); Q1 2026 Earnings Call Transcript (April 29, 2026). All consensus figures as of July 28, 2026.

Table 2 — Beat/Miss History: Last 8 Quarters (Revenue & Adj. Operating EPS)

Quarter

Revenue Reported ($M)

Revenue Consensus ($M)

Rev. Surprise %

Adj. EPS Reported ($)

Adj. EPS Consensus ($)

EPS Surprise %

Result

Q2 2024

$716.8M

$722.6M

-0.8%

$1.74

$1.64

+6.1%

Rev Miss / EPS Beat

Q3 2024

$725.3M

$721.9M

+0.5%

$1.67

$1.60

+4.4%

Beat / Beat

Q4 2024

$735.6M

$734.3M

+0.2%

$1.61

$1.59

+1.3%

Beat / Beat

Q1 2025

$753.0M

$750.8M

+0.3%

$1.73

$1.68

+3.0%

Beat / Beat

Q2 2025

$772.6M

$769.4M

+0.4%

$1.88

$1.77

+6.2%

Beat / Beat

Q3 2025

$768.3M

$776.8M

-1.1%

$1.72

$1.71

+0.6%

Rev Miss / EPS Beat

Q4 2025

$778.8M

$773.5M

+0.7%

$1.82

$1.60

+13.8%

Beat / Beat

Q1 2026

$782.6M

$772.6M

+1.3%

$1.82

$1.74

+4.6%

Beat / Beat

Pattern: VRSK has beaten adjusted EPS consensus in all 8 of the last 8 quarters, with an average EPS surprise of ~+5.1%. Revenue beats are less consistent (6 of 8), with the two misses driven by weather-related transactional revenue shortfalls (Q2 2024, Q3 2025). The consistent EPS beat pattern reflects strong cost discipline and buyback tailwinds even when revenue disappoints.

Source: Visible Alpha Consensus and Actuals Data.

3. Guidance & Commentary Evolution

Key Takeaway: Full-year 2026 guidance was reaffirmed in full at Q1 earnings (April 29) and has not been formally revised since. Management tone has shifted modestly more constructive since Q1 — at Bernstein (May 28) and William Blair (June 2), CEO Shavel confirmed Q1 was the trough and expressed confidence in building momentum through Q2 and into H2, though no specific Q2 numerical guidance was provided.

Metric

Initial Guidance (Q1 2026 Earnings Call, Apr 29)

Revised Guidance

Current Consensus (Jul 28)

Note

FY 2026 Revenue

$3,190M – $3,240M

$3,223M

Unchanged; consensus sits near midpoint

FY 2026 Adj. EBITDA

$1,790M – $1,830M

$1,818M

Unchanged; consensus slightly above midpoint

FY 2026 Adj. EBITDA Margin

56.0% – 56.5%

~56.4%

Unchanged; consensus near top of range

FY 2026 Diluted Adj. EPS

$7.45 – $7.75

$7.67

Unchanged; consensus above midpoint ($7.60)

FY 2026 CapEx

$260M – $280M

N/A

Unchanged

FY 2026 Net Interest Expense

$190M – $200M

N/A

Unchanged

FY 2026 Effective Tax Rate

23.0% – 26.0%

N/A

Unchanged

Q2 2026 OCC Growth (qualitative)

May still fall below 6–8% LT range (CFO, Apr 29)

→ Upgraded to 'continued momentum' (CEO, May 28 Bernstein)

~5.3% consensus

↑ Tone improved post-Q1; CEO confirmed Q1 was trough at Bernstein (May 28, 2026)

Sources: Q1 2026 Earnings Release and Transcript (April 29, 2026); Bernstein 42nd Annual Strategic Decisions Conference Transcript (May 28, 2026); William Blair Growth Stock Conference Transcript (June 2, 2026); Visible Alpha Consensus Data.

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates for Q2 2026 and FY 2026 have been remarkably stable since the Q1 print — revenue and EPS consensus have drifted only marginally since the April 29 baseline. The lack of meaningful downward revision despite management's cautious Q2 language suggests the street has already priced in the trough, and any upside from weather normalization or subscription acceleration would be incremental to current expectations.

KPI (Period)

Estimate ~5 Days Post Q1 Earnings (as of May 6, 2026)

Current Consensus (Jul 28, 2026)

Estimate Δ (%)

Initial Guidance (Q1 Earnings Call)

Current Guidance

Guidance Δ

Consensus vs. Guidance

Revenue — Q2 2026

$801.8M

$804.5M

+0.3%

No specific Q2 guidance

No specific Q2 guidance

N/A

N/A

Revenue — FY 2026

$3,216.8M

$3,223.1M

+0.2%

$3,190–$3,240M

$3,190–$3,240M (unchanged)

0%

+0.2% above midpoint

Adj. Operating EPS — Q2 2026

$1.91

$1.93

+1.0%

No specific Q2 guidance

No specific Q2 guidance

N/A

N/A

Adj. Operating EPS — FY 2026

$7.65

$7.67

+0.3%

$7.45–$7.75

$7.45–$7.75 (unchanged)

0%

+0.9% above midpoint ($7.60)

Adj. EBITDA — Q2 2026

$454.3M

$456.9M

+0.6%

No specific Q2 guidance

No specific Q2 guidance

N/A

N/A

Adj. EBITDA — FY 2026

$1,810.3M

$1,818.0M

+0.4%

$1,790–$1,830M

$1,790–$1,830M (unchanged)

0%

+0.4% above midpoint ($1,810M)

OCC Growth — Q2 2026

~5.3%

~5.3%

Flat

May fall below 6–8% LT range

Unchanged (qualitative)

N/A

Below LT range; consistent with guidance

Estimates have been essentially flat since the Q1 print, with Q2 revenue up just +0.3% and FY EPS up +0.3% from the post-earnings baseline. This stability reflects the street's acceptance of management's trough narrative and the absence of any negative pre-announcement. Consensus sits modestly above FY guidance midpoints across all metrics, implying the street expects a slight H2 acceleration — consistent with management's messaging.

Source: Visible Alpha Consensus and Actuals Data (as-of dates: May 6, 2026 and July 28, 2026); Q1 2026 Earnings Call Transcript.

5. Stock Performance

Key Takeaway: VRSK has rallied ~12.8% since the Q1 2026 earnings date (April 29), underperforming the KIE insurance ETF (+16.1%) but significantly outperforming the S&P 500 (+4.1%). The move has been almost entirely multiple-driven — NTM EV/EBITDA expanded from ~13.96x (3 months ago) to ~16.36x today, while estimate revisions have been flat — suggesting the stock has re-rated on improved sentiment and the trough narrative rather than fundamental upgrades.

Indexed Performance Since April 29, 2026 (Base = 100):

Date

VRSK (Indexed)

KIE (Indexed)

SPY (Indexed)

Apr 29, 2026 (Base)

100.0

100.0

100.0

May 14, 2026 (Trough)

83.3

98.3

105.1

May 28, 2026 (Bernstein Conf.)

91.8

97.3

106.0

Jun 2, 2026 (William Blair Conf.)

95.2

96.4

106.7

Jun 30, 2026 (Quarter End)

95.4

106.6

104.9

Jul 16, 2026 (TRV Earnings)

107.1

110.9

105.5

Jul 28, 2026 (Current)

112.8

116.1

104.1

Note: KIE = SPDR S&P Insurance ETF (sub-sector benchmark for VRSK's primary end market). VRSK hit a post-earnings trough of ~$156.84 on May 14 (down ~16.7% from the April 29 close) before recovering sharply. The recovery coincided with the Bernstein conference (May 28) where management confirmed Q1 as the trough, and accelerated in July as insurance peers (TRV, CB, HIG) reported strong Q2 results, lifting the KIE and dragging VRSK higher. The 12-month NTM EV/EBITDA multiple has compressed from ~24.7x to ~16.4x, but the 1-month and 3-month re-expansion (+13.5% and +17.2% respectively) reflects improving sentiment.

Source: Stock Price Data (Yahoo Finance); Stock Performance Decomposition Data.

6. Material News & Developments

Key Takeaway: The most material development since Q1 earnings is the July 27 CIO departure (effective August 3), which adds a leadership uncertainty overhang at a critical AI execution juncture; however, the interim CTO-to-CIO transition and the strategic advisor role suggest a managed handoff. The Synergy Studio launch (June 2026) and MCP connector deployments are positive product catalysts heading into the print.

7. Peer Commentaries — Q2 2026 Current-Quarter Read-Through

Scope Note: This section includes only commentary and conditions from peers' own Q2 2026 reporting quarter (calendar quarter ended June 30, 2026), reported or discussed in the last 60 days through July 28, 2026. Prior-quarter results and forward-looking commentary about future quarters are excluded.

Key Takeaway: Peer Q2 2026 results paint a constructive backdrop for VRSK: insurance carriers reported strong profitability and robust technology/AI investment, catastrophe losses were elevated but manageable (positive for transactional revenue), and data/analytics peers (MCO, SPGI) reported accelerating demand for AI-integrated data solutions with MCP adoption gaining traction. The primary caution is that carriers are more rigorously scrutinizing AI ROI and that sales cycles for complex AI contracts are elongating — consistent with VRSK's own Q1 commentary.

7a. Progressive (PGR) — Q2 2026 Results (Reported July 15, 2026)

Q2 2026 Conditions Relevant to VRSK:

7b. Travelers (TRV) — Q2 2026 Results (Reported July 17, 2026)

7c. Chubb (CB) — Q2 2026 Results (Reported July 22, 2026)

7d. The Hartford (HIG) — Q2 2026 Results (Reported July 24, 2026)

7e. S&P Global (SPGI) — Q2 2026 Results (Reported July 28, 2026)

7f. Moody's (MCO) — Q2 2026 Results (Reported July 22, 2026)

Peer Read-Through Summary Table

Theme

Signal

Key Peers

VRSK Implication

Q2 2026 Weather / Cat Activity

Positive

PGR, TRV, CB, HIG

More normalized cat losses vs. near-zero 2025 → transactional revenue tailwind

Carrier Technology / AI Investment

Positive

TRV, CB, HIG

Carriers investing $1.5B+/yr in AI/tech; validates VRSK demand environment

AI Data Demand Acceleration

Positive

SPGI, MCO

MCP adoption accelerating; AI customers growing ACV 60% faster (SPGI)

Elongated AI Sales Cycles

Cautionary

SPGI, MCO

Complex AI contract negotiations extending sales cycles; known headwind, already flagged by VRSK

Soft Market Spreading to Casualty

Cautionary

CB, HIG

Soft pricing in property/casualty reduces formula-driven NWP tailwind for VRSK pricing contracts

Insurer Profitability

Positive

TRV, CB, HIG

Strong carrier ROEs support technology investment budgets

Cloud Migration / Vendor Consolidation

Positive

MCO, SPGI

Multi-year cloud migration tailwind; vendor consolidation benefits integrated providers like VRSK

Rising Casualty Loss Costs

Positive

CB, HIG

6–7% primary casualty / 9–12% excess loss cost inflation → demand for VRSK casualty analytics

Sources: Progressive Q2 2026 Earnings Release (July 15, 2026); Travelers Q2 2026 Earnings Call Transcript (July 17, 2026); Chubb Q2 2026 Earnings Call Transcript (July 22, 2026); The Hartford Q2 2026 Earnings Call Transcript (July 24, 2026); S&P Global Q2 2026 Earnings Call Transcript (July 28, 2026); Moody's Q2 2026 Earnings Call Transcript (July 22, 2026).

8. Insider Transaction Activity

Key Takeaway: No open-market buys from insiders since Q1 earnings. CFO Elizabeth Mann has executed three small, pre-planned 10b5-1 sales (400 shares each in May, June, and July) at prices ranging from ~$170–$200 — routine and obligation-driven. The only discretionary sale was Director Samuel Liss's 4,671-share open-market sale on June 5 at ~$178.97, which is notable given the stock was near its post-earnings trough at the time. No insider buying signals; the Liss sale at the trough is a mild negative signal but not alarming given the small size relative to his remaining 69,098 shares.

Name

Title

Transaction Type

Shares

Est. Value

Transaction Date

Filing Date

Note

Elizabeth Mann

CFO

10b5-1 Planned Sale

400

~$76,844

Jul 15, 2026

Jul 15, 2026

Pre-planned 10b5-1 (plan initiated Dec 11, 2025); ~2% of holdings; routine

Elizabeth Mann

CFO

10b5-1 Planned Sale

400

~$71,844

Jun 15, 2026

Jun 16, 2026

Pre-planned 10b5-1; routine monthly sale; ~2% of holdings at time of sale

Samuel G. Liss

Director

Open Market Sale

4,671

~$835,000 (est. at ~$178.97)

Jun 5, 2026

Jun 8, 2026

Discretionary open-market sale; no 10b5-1 plan; sold near post-earnings trough; retains 69,098 shares

Elizabeth Mann

CFO

10b5-1 Planned Sale

400

~$68,348

May 15, 2026

May 15, 2026

Pre-planned 10b5-1; routine monthly sale; stock near post-earnings trough (~$162)

Source: SEC Form 4 Filings Database; SEC EDGAR (Form 4 filings for VRSK, May–July 2026).

9. Key Risks & Questions for the Call

Key Takeaway: The primary risks heading into the print are (1) transactional revenue remaining depressed despite weather normalization, (2) AI sales cycle elongation delaying monetization, and (3) the CIO transition creating execution uncertainty at a critical technology juncture.

Key Questions for Management on the Q2 2026 Earnings Call

  1. Transactional Revenue Recovery: How much did weather normalization in Q2 2026 contribute to transactional revenue? Is the -3.6% consensus estimate for transactional OCC growth achievable, or did weather remain below historical norms?
  2. OCC Growth Trajectory: Did Q2 OCC growth fall below the 6–8% long-term target range as guided, and what is the specific expectation for Q3 and Q4 to achieve the full-year ~6.1% consensus?
  3. MCP Connector Update: How many trials have been initiated for the Anthropic MCP connectors? What is the timeline to paid monetization, and are there additional connector launches planned?
  4. Synergy Studio Launch: Has Synergy Studio launched in production as planned in June 2026? What is the initial client uptake, and how does the open ecosystem model differentiate VRSK from MCO's Intelligent Risk Platform?
  5. ASR Settlement: What is the final settlement price and total shares retired under the $1.5B ASR? What is the remaining share repurchase authorization?
  6. CIO Transition: What is the timeline for finding a permanent CIO? How does the transition affect the AI product roadmap, and what is Jeff Negrete's mandate as interim CIO?
  7. Federal Government Contract: Has the work stoppage in the federal government contract been fully resolved? What is the expected contribution from this contract in H2 2026?
  8. AI Sales Cycle Elongation: How are AI governance and compliance negotiations progressing with large clients? Are extended sales cycles improving, stable, or worsening relative to Q1?

Appendix: Valuation Context

NTM Valuation Multiples (as of July 28, 2026):

Metric

Current (Jul 28, 2026)

3 Months Ago

6 Months Ago

12 Months Ago

NTM EV/EBITDA

16.36x

13.96x

17.86x

24.70x

NTM EV/Sales

9.27x

7.88x

10.07x

13.76x

NTM P/E

26.17x

23.52x

29.76x

41.42x

NTM P/FCF

23.05x

20.75x

26.27x

36.88x

Stock Price

$212.26

~$174.99 (Apr 29 +3M)

~$219.60 (Jan 28)

~$298.00 (Jul 28, 2025)

The stock is down ~28.8% over the trailing 12 months, with the decline almost entirely driven by multiple compression (NTM EV/EBITDA from 24.7x to 16.4x, a -33.8% contraction). Over the past 3 months, the stock has recovered +21.4%, with multiple expansion accounting for +17.2% of the move. At 16.4x NTM EV/EBITDA, VRSK trades at a meaningful discount to its 5-year historical average but at a premium to generic business services peers, reflecting the subscription model quality and data moat. The trough narrative is well-understood; a Q2 beat and H2 acceleration guidance would likely drive further multiple re-expansion toward the 18–20x range.

Source: Stock Performance Decomposition Data; Stock Price Data (Yahoo Finance).

Adj. EPS Revision Momentum (Q2 2026 Consensus, Monthly Snapshots):

Month-End

Q2 2026 Adj. EPS Consensus

VRSK Stock Price

Aug 2025

$1.901

$268.12

Sep 2025

$1.894

$251.51

Oct 2025

$1.864

$218.76

Nov 2025

$1.859

$225.07

Dec 2025

$1.859

$223.69

Jan 2026

$1.869

$217.46

Feb 2026

$1.843

$207.57

Mar 2026

$1.846

$189.75

Apr 2026

$1.848

$184.49

May 2026

$1.829

$174.99

Jun 2026

$1.838

$179.53

Jul 2026 (latest)

$1.841

$212.30

EPS Revision Commentary: Q2 2026 adj. EPS consensus has declined from $1.901 (August 2025) to $1.841 (July 2026), a cumulative revision of -3.2% over the trailing 12 months. The bulk of the downward revision occurred between August and November 2025 (-2.2%), coinciding with the AccuLynx deal complications and the emergence of weather headwinds. Since January 2026, estimates have been essentially flat ($1.843–$1.841), suggesting the street has fully digested the trough narrative and is not pricing in further deterioration. The stock's recovery from its May 2026 trough ($174.99) to $212.30 has been driven entirely by multiple re-expansion rather than estimate upgrades, which is a less durable form of appreciation heading into the print.

Source: Earnings and Earnings Revision Momentum Data (Visible Alpha / Implied Platform).

— End of Report —

Disclaimer: This earnings preview is prepared for informational purposes only based on publicly available information and consensus data as of July 28, 2026. It does not constitute investment advice. All Visible Alpha consensus data sourced from Visible Alpha Consensus and Actuals Database. Stock price data sourced from Yahoo Finance. Insider transaction data sourced from SEC EDGAR Form 4 filings. Peer commentary sourced from publicly available earnings call transcripts and press releases.